Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Translation value of the bleomycin rat model for the treatment of patients with Idiopathic Pulmonary Fibrosis (IPF)


ABSTRACT: Intratracheal application of bleomycin is known to induce inflammatory and fibrotic reactions in the lung within a short period of time and histological features include infiltration of inflammatory cells, collagen deposition and obliteration of alveolar spaces. Because some of these features are found in patients with idiopathic pulmonary fibrosis (IPF), the bleomycin-induced lung fibrosis animal model is commonly used. However, exploratory treatments that were successfully used in this animal model and progressed to clinical trials lacked significant efficacy in humans. Here, the bleomycin-induced rat lung fibrosis model was studied using whole genome expression data that was collected at various time points and the relevance to human disease was evaluated through comparison with whole genome expression data from IPF patient-derived lung biopsies. The highest gene expression correlation between both species was observed in animals 7 days after bleomycin instillation. These gene expression signatures helped to identify a set of twelve novel disease-relevant translational gene markers that were able to separate IPF patients from controls. Furthermore, three Wnt/-catenin pathway-related genes that belong to this translational gene marker set showed, together with clinical diffusing capacity of the lung for carbon monoxide (DLCO) measurements, the potential to stratify IPF patients according to disease severity. Pirfenidone attenuated a subset of the translational gene markers in the bleomycin-induced fibrosis model, in particular those related to Wnt/-catenin-signaling. This novel translational gene marker panel offers improved possibilities to evaluate disease-modifying efficacy of novel therapeutic concepts in the bleomycin-induced rat lung fibrosis model and could be applied as a diagnostic and prognostic tool for IPF patient care. Comparison of bleomycin-treated and control rats after 3 days, 1 week, 2 weeks, 3 weeks, 4 weeks, 6 weeks and 8 weeks; 5 animals per group

ORGANISM(S): Rattus norvegicus

SUBMITTER: Axel Klenk 

PROVIDER: E-GEOD-48455 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.

Bauer Yasmina Y   Tedrow John J   de Bernard Simon S   Birker-Robaczewska Magdalena M   Gibson Kevin F KF   Guardela Brenda Juan BJ   Hess Patrick P   Klenk Axel A   Lindell Kathleen O KO   Poirey Sylvie S   Renault Bérengère B   Rey Markus M   Weber Edgar E   Nayler Oliver O   Kaminski Naftali N  

American journal of respiratory cell and molecular biology 20150201 2


The bleomycin-induced rodent lung fibrosis model is commonly used to study mechanisms of lung fibrosis and to test potential therapeutic interventions, despite the well recognized dissimilarities to human idiopathic pulmonary fibrosis (IPF). Therefore, in this study, we sought to identify genomic commonalities between the gene expression profiles from 100 IPF lungs and 108 control lungs that were obtained from the Lung Tissue Research Consortium, and rat lungs harvested at Days 3, 7, 14, 21, 28,  ...[more]

Similar Datasets

2014-10-28 | GSE48455 | GEO
2024-09-10 | PXD026222 | Pride
2021-02-13 | GSE166682 | GEO
2023-02-06 | PXD029625 | Pride
2013-05-26 | E-GEOD-37635 | biostudies-arrayexpress
2017-03-20 | E-MTAB-5619 | biostudies-arrayexpress
2024-09-17 | GSE248263 | GEO
2024-05-21 | GSE267904 | GEO
2022-05-06 | GSE130983 | GEO
2023-01-05 | GSE173523 | GEO